BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15868377)

  • 1. Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.
    Liang J; Moore RE; Moher ED; Munroe JE; Al-awar RS; Hay DA; Varie DL; Zhang TY; Aikins JA; Martinelli MJ; Shih C; Ray JE; Gibson LL; Vasudevan V; Polin L; White K; Kushner J; Simpson C; Pugh S; Corbett TH
    Invest New Drugs; 2005 Jun; 23(3):213-24. PubMed ID: 15868377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin.
    Corbett TH; Panchapor C; Polin L; Lowichik N; Pugh S; White K; Kushner J; Meyer J; Czarnecki J; Chinnukroh S; Edelstein M; LoRusso P; Heilbrun L; Horwitz JP; Grieshaber C; Perni R; Wentland M; Coughlin S; Elenbaas S; Philion R; Rake J
    Invest New Drugs; 1999; 17(1):17-27. PubMed ID: 10555119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical anticancer activity of cryptophycin-8.
    Corbett TH; Valeriote FA; Demchik L; Polin L; Panchapor C; Pugh S; White K; Knight J; Jones J; Jones L; LoRusso P; Foster B; Wiegand RA; Lisow L; Golakoti T; Heltzel CE; Ogino J; Patterson GM; Moore RE
    J Exp Ther Oncol; 1996 Mar; 1(2):95-108. PubMed ID: 9414393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
    Shih C; Teicher BA
    Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
    Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
    J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169.
    Corbett TH; White K; Polin L; Kushner J; Paluch J; Shih C; Grossman CS
    Invest New Drugs; 2003 Feb; 21(1):33-45. PubMed ID: 12795528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of cryptophycin analogs with substitution at C-6 (fragment C region).
    Varie DL; Shih C; Hay DA; Andis SL; Corbett TH; Gossett LS; Janisse SK; Martinelli MJ; Moher ED; Schultz RM; Toth JE
    Bioorg Med Chem Lett; 1999 Feb; 9(3):369-74. PubMed ID: 10091686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptophycin-55/52 based antibody-drug conjugates: Synthesis, efficacy, and mode of action studies.
    Lai Q; Wu M; Wang R; Lai W; Tao Y; Lu Y; Wang Y; Yu L; Zhang R; Peng Y; Jiang X; Fu Y; Wang X; Zhang Z; Guo C; Liao W; Zhang Y; Kang T; Chen H; Yao Y; Gou L; Yang J
    Eur J Med Chem; 2020 Aug; 199():112364. PubMed ID: 32402935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel cryptophycin analogs with modification in the beta-alanine region.
    Shih C; Gossett LS; Gruber JM; Grossman CS; Andis SL; Schultz RM; Worzalla JF; Corbett TH; Metz JT
    Bioorg Med Chem Lett; 1999 Jan; 9(1):69-74. PubMed ID: 9990459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors.
    Boinpally RR; Polin L; Zhou SL; Jasti BR; Wiegand RA; White K; Kushner J; Horwitz JP; Corbett TH; Parchment RE
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):25-33. PubMed ID: 12739061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of cryptophycins: effect of infusion time and combination studies.
    Menon K; Alvarez E; Forler P; Phares V; Amsrud T; Shih C; Al-Awar R; Teicher BA
    Cancer Chemother Pharmacol; 2000; 46(2):142-9. PubMed ID: 10972484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First generation design, synthesis, and evaluation of azepine-based cryptophycin analogues.
    Smith AB; Cho YS; Zawacki LE; Hirschmann R; Pettit GR
    Org Lett; 2001 Dec; 3(25):4063-6. PubMed ID: 11735585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of DMP 840 against mouse and human solid tumor models.
    LoRusso P; Demchik L; Dan M; Polin L; Gross JL; Corbett TH
    Invest New Drugs; 1995; 13(3):195-203. PubMed ID: 8729946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
    Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
    Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
    Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
    Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs.
    Schmidt JJ; Khatri Y; Brody SI; Zhu C; Pietraszkiewicz H; Valeriote FA; Sherman DH
    ACS Chem Biol; 2020 Feb; 15(2):524-532. PubMed ID: 31961651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity.
    Al-Awar RS; Corbett TH; Ray JE; Polin L; Kennedy JH; Wagner MM; Williams DC
    Mol Cancer Ther; 2004 Sep; 3(9):1061-7. PubMed ID: 15367700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of cryptophycin-1 and BCN-183577: examples of strategies and problems in the detection of antitumor activity in mice.
    Corbett TH; Valeriote FA; Demchik L; Lowichik N; Polin L; Panchapor C; Pugh S; White K; Kushner J; Rake J; Wentland M; Golakoti T; Hetzel C; Ogino J; Patterson G; Moore R
    Invest New Drugs; 1997; 15(3):207-18. PubMed ID: 9387043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.